NASDAQ · Biotechnology

NAUT (NAUT) Stock

$0.92 -4.40% NASDAQ: NAUT Healthcare

Valuation

MetricValue
Price$0.92
Market Cap$117.01M
P/E Ratio-2.04
P/B Ratio0.89
P/S Ratio615.85
EPS (TTM)$-0.47
52-Week High$4.31
52-Week Low$0.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-37.58%
ROA-34.55%
ROCE-40.52%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.21
Current Ratio13.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-50.0M$-64.0M$-76.0M$-81.0M$-67.0M
Net Profit$-50.0M$-58.0M$-64.0M$-71.0M$-59.0M
EPS$-0.60$-0.46$-0.51$-0.56$-0.47
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$398.0M$350.0M$306.0M$243.0M$191.0M
Total Liabilities$35.0M$35.0M$40.0M$34.0M$34.0M
Cash$186.0M$115.0M$19.0M$28.0M$12.0M
Borrowings$30.0M$30.0M$35.0M$30.0M$30.0M

Latest News

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 GlobeNewswire · Jul 8, 2026 3 Penny Stocks With Market Caps Over $100M To Watch Simply Wall St. · Jun 3, 2026 3 Promising Penny Stocks With Market Caps Up To $900M Simply Wall St. · May 5, 2026 Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans Simply Wall St. · May 5, 2026 Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... GuruFocus.com · Apr 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-39.0M$-46.0M$-52.0M$-59.0M$-51.0M
Investing Cash Flow$-141.0M$-28.0M$-46.0M$64.0M$34.0M
Financing Cash Flow$335.0M$0$0$0$0
Net Cash Flow$149.0M$-71.0M$-95.0M$8.0M$-15.0M
Free Cash Flow$-42.0M$-48.0M$-54.0M$-61.0M$-52.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.14
EV / EBITDA-2.39
FCF Yield-44.32%
Quick Ratio10.14
Interest Coverage0.00
Return 1Y138.87%
Return 3Y-44.86%
Return 5Y-81.00%

Ownership

Insiders Held33.21%
Institutions Held40.78%
Institutions Float Held61.05%
Institutional HolderSharesReport Date
a16z Capital Management, L.L.C.17,653,9172026-03-31
Perceptive Advisors Llc12,594,2112026-03-31
Cercano Management Llc7,172,9852026-03-31
Vanguard Capital Management LLC2,545,5972026-03-31
Clearstead Advisors, LLC2,329,7842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARCT $15.56 -7.05% -2.93 $442.26M 0.00%
ASMB $36.13 -1.61% -51.53 $716.00M 0.00%
ENTA $14.02 -0.50% -6.04 $407.68M 0.00%
FHTX $4.87 -5.80% -5.22 $285.94M 0.00%
HUMA $0.60 -0.10% -4.19 $100.13M 0.00%

About NAUT

NAUT is led by CEO Sujal Patel, employs 134 people, headquartered in US, publicly traded since 2020.

NAUT stock trades at $0.92 with a market capitalization of $117.01M. The stock is valued at a price-to-earnings (P/E) ratio of -2.04, price-to-book of 0.89, price-to-sales of 615.85. Over the past 52 weeks the stock has ranged between $0.65 and $4.31, and currently trades 78.7% below its 52-week high.

On profitability, NAUT generates a return on equity (ROE) of -37.58%, return on capital employed of -40.52%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.50 -0.05% JNJ Drug Manufacturers - General $278.43 +1.17% ABBV Drug Manufacturers - General $260.30 -0.54% MRK Drug Manufacturers - General $152.34 +0.46% UNH Medical - Healthcare Plans $400.94 +0.32% NVS Drug Manufacturers - General $163.09 +0.39% AZN Drug Manufacturers - General $164.77 +1.94% AMGN Drug Manufacturers - General $444.12 +0.29% TMO Medical - Diagnostics & Research $618.43 +1.63% NVO Biotechnology $47.51 +1.58% ABT Medical - Devices $108.80 -1.51% GILD Drug Manufacturers - General $151.22 +1.08%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides